Skip to main content
Download PDF
  • Research note
  • Open access
  • Published:

The type of anticoagulant used for plasma collection affects in vitro Rhodococcus equi assays

BMC Research Notes volume 15, Article number: 50 (2022) Cite this article

Abstract

Objective

The efficacy of Rhodococcus equi-specific hyperimmune plasma (HIP) is usually evaluated in vitro. Anticoagulants (AC) used for plasma collection can negatively impact bacterial replication but their effect on R. equi growth has not been evaluated. The aim of this study was to establish the effect that AC routinely used in veterinary medicine (ACD, K2EDTA, Li Heparin, and Na Citrate) have on in vitro R. equi growth. To assess this, in vitro assays commonly used to test HIP efficacy (direct effect on microorganism and macrophage infection), were performed using each AC and non-treated bacteria.

Results

There was no direct effect of ACD, Li Heparin or Na Citrate on R. equi growth. These AC significantly (p < 0.05) delayed growth for 12 h following opsonization. The number of R. equi colonies after macrophage infection was significantly (p < 0.05) lower 72 h post-opsonization with Na Citrate. K2EDTA inhibited the formation of R. equi colonies by 12 h in all the assays. In conclusion, AC should be taken into consideration when interpreting in vitro results as their negative effect on bacterial growth may be mistakenly interpreted as HIP efficacy. ACD and Li Heparin appear more appropriate for the selected assays.

Introduction

Rhodococcus equi (R. equi) is a Gram-positive bacterium that infects macrophages and causes bronchopneumonia [1, 2] and extrapulmonary disease [3, 4] in young foals worldwide. There is no vaccine against this condition; therefore, R. equi-specific hyperimmune plasma of equine origin (HIP) is administered to neonatal foals for prophylaxis. However, the protective mechanism of HIP is poorly understood [5,6,7]. The in vivo study of HIP is complicated by the fact that animals such as mice [8] and guinea pigs [9] don’t develop typical lesions after experimental infection. As a result, in vitro assays are used to investigate the effect that HIP has on R. equi infection of macrophages [10, 11].

Multiple in vitro studies have evaluated the effect that HIP has on R. equi intracellular survival [10, 12, 13]; however, little attention has been paid to the type of anticoagulant (AC) used to collect these plasma products. Sodium citrate (Na Citrate) is commonly used to collect large volumes of plasma but other AC such as acid citrate dextrose (ACD), ethylenediaminetetraacetic acid (EDTA), and lithium heparin (Li Heparin) are also used. These compounds prevent blood coagulation by different mechanisms and in addition, some directly compromise in vitro growth of microorganisms [14,15,16]. However, the effect that AC may have on R. equi in vitro assays has not been evaluated. Failure to recognize these effects can lead to misinterpretation of the data and result in inappropriate estimation of product efficacy [14] jeopardizing patient safety. The objective of this study was to evaluate the effect that routinely used AC namely ACD, K2EDTA, Li Heparin and Na Citrate have on commonly performed R. equi in vitro assays.

Main text

Methods

Bacterial strain and growth

Pathogenic R. equi #ATCC 103+ expressing gfp gene [17] was cultured from glycerol stock on brain heart infusion (BHI; BD Difco, MD) agar plates at 37 °C for 48 h. A colony was inoculated in 5 mL of BHI following incubation (37 °C for 18 h). Concentration was estimated using optical density and confirmed by dilution plating and colony forming unit (CFU) counts after 48 h.

Cell culture

Murine macrophages RAW264.7 (ATCC TIB-71, MD) were irradiated as previously described [18] to prevent cell multiplication. Cells were maintained in Dulbecco's Modified Eagle Medium (DMEM; Gibco, NY) containing 10% fetal bovine serum, and 1% penicillin–streptomycin (Sigma Aldrich, MO).

Anticoagulant effect on R. equi growth

Media (BHI) was added to Vacutainer tubes® (BD, NJ) containing K2EDTA, Li Heparin, Na Citrate or ACD (1:7 AC:BHI). Thereafter, 0.5 mL of BHI-AC was mixed with 1.5 mL of BHI containing 1–3 × 104 CFU of R. equi. Tubes were incubated at 37 ºC and CFU/mL were calculated at 0, 8, 12, 18, 24, and 32 h post-incubation (time to stationary phase) by serial plate dilution. R. equi was also grown in BHI without AC (positive control) and in BHI/PBS (1:7) to account for dilution.

Plasma effect on R. equi growth

Plasma from two healthy horses from the Washington State University research herd was collected using Vacutainer® tubes containing the AC above mentioned. Serum was also collected. Briefly, whole blood was collected in the tubes and centrifuged at 500×g 15 min to allow separation of the plasma/serum from the red blood cells. Plasma/serum (0.5 mL) from each horse was mixed with 1.5 mL of BHI containing 1–3 × 104 CFU R. equi. Tubes were incubated at 37 ºC and CFU/mL were calculated at 0, 6, 12, 18, 24, and 32 h post-incubation using serial dilution.

R. equi opsonization

Opsonization was performed as previously described [19]. Briefly, plasma and serum from 3 healthy horses from the WSU research herd was collected as described above and pooled. Each plasma/serum was mixed with BHI containing 1–3 × 106 CFU/mL of R. equi (v/v 1:3) for 30 min at 37 °C 60 rpm. Thereafter, bacteria were washed with PBS, resuspended in phagocytic media, and used for intracellular infections. Non-opsonized R. equi that underwent the same manipulation was also included.

Intracellular assay

Infections were performed as described before [10] with modifications. Briefly, RAW264.7 monolayers (1 × 105 cells/well) were incubated overnight on 24-well tissue culture plates (Eppendorf, Germany) and washed with warm PBS prior to infection. Phagocytic buffer containing opsonized or non-opsonized R. equi at multiplicity of infection of 20 was added to each well and cells were incubated 1 h at 37 °C. Monolayers were then washed to remove unbound bacteria; and incubated 30 min for bound bacteria to be internalized. Media was replaced with complete DMEM (cDMEM) with 20 μg/mL of amikacin sulfate for 1 h to kill extracellular bacteria. Cells were then washed and incubated in cDMEM until lysis at 0, 24, 48, and 72 h post-infection and detachment for fluorescence microscopy (24 h). Lysis was achieved using saponin 0.1%, scraping, microtube homogenizer and centrifugation (10,000×g 10 min). Bacterial growth was determined by dilution plating of lysates.

Fluorescence microscopy

Infected cells were detached using cell dissociation buffer (Thermo Fisher, MA) immediately (T0) and 24 h after infection. Cells were stained with ProLong™ Gold-Antifade-Mountant with DAPI (Invitrogen, CA). Three hundred macrophages were counted and the number of infected cells and cells with 10 or more bacteria were established using the ImageJ software (NIH, Bethsda, MD) as described before [10].

Statistical analysis

Data were analyzed using R studio statistical software (https://www.r-project.org/). Normality and variance were assessed with Shapiro-Wilks and Levene’s tests respectively. For CFU/mL data analysis was log transformed. Changes in CFU/mL for BHI and plasma assays were evaluated using repeated measures two-factor analysis of variance (ANOVA) with interaction using a random effect. Changes in intracellular CFU/mL were evaluated using repeated measures two-factor ANOVA. Post-Hoc tests were conducted using the Dunnett’s test. The experiments were performed in duplicates and repeated on 3 different days. Significance was set up at p < 0.05.

Results

Anticoagulant effect on R. equi growth

R. equi concentration was not different between groups at T0. CFU/mL significantly (p < 0.001) increased 8 h post-inoculation and at every timepoint thereafter in BHI and BHI/PBS. Similar growth overtime was observed in tubes with ACD, Li Heparin and Na Citrate. No significant differences were observed in the number of CFU/mL between these groups at any time. In contrast, R. equi cultured in K2EDTA tubes had significantly (p < 0.001) lower CFU/mL by 8 h post-inoculation. Moreover, there were no visible CFU by 18 h post-inoculation; thus, CFU/mL were significantly (p < 0.001) lower than the rest of the groups at all time points thereafter (Fig. 1).

Fig. 1
figure 1

R. equi (log CFU/mL) after 0.5 mL of plasma collected with different AC (ACD, K2EDTA, Li Heparin, Na Citrate) was mixed with 1.5 mL of BHI containing 1–3 × 104 CFU of R. equi for 32 h at 37 ºC. CFU/mL were counted immediately after mixing (T0) and 8, 12, 18, 24, and 32 h thereafter. BHI, and BHI/PBS were added as controls. Asterisks (*) indicate significant change in CFU/mL from T0 (p < 0.001) by group. Letters indicates significant (p < 0.001) differences in CFU/mL between groups at a specific timepoint

Full size image

Plasma effect on R. equi growth

R. equi CFU/mL significantly (p < 0.001) increased by 6 h post-inoculation in BHI and BHI/PBS. R. equi cultured in serum or plasma collected using ACD, Li Heparin, and Na Citrate grew significantly (p < 0.05) at every time point from 12 h post-inoculation. There was no significant difference in CFU/mL between these groups at any time. Tubes incubated with plasma containing K2EDTA had significantly (p < 0.001) lower CFU/mL by 6 h post-inoculation and had no visible CFU by 18 h post-inoculation. Thus, CFU/mL were significantly (p < 0.001) lower than the rest of the groups at all time points thereafter (Fig. 2).

Fig. 2
figure 2

R. equi (log CFU/mL) after 0.5 mL of serum or plasma collected with different AC (ACD, K2EDTA, Li Heparin, and Na Citrate) were mixed with 1.5 mL of BHI containing 1–3 × 104 CFU/mL of R. equi for 32 h at 37 ºC. CFU/mL were counted immediately after mixing (T0) and 6, 12, 18, 24, and 32 h thereafter. BHI, and BHI/PBS were added as controls. Asterisks (*) indicate significant change in CFU/mL from T0 (p < 0.05) by group. Different letters denote significant (p < 0.05) differences in CFU/mL between groups at a specific timepoint

Full size image

Intracellular assay

At T0, there were no differences in CFU/mL between groups. Non-opsonized R. equi (CFU/mL) grew significantly (p = 0.0082) overtime inside macrophages after 24 h post-infection. While R. equi opsonized with serum or plasma collected with ACD, Li Heparin, and Na Citrate, grew significantly (p < 0.001) inside macrophages by 48 and 72 h post-infection; growth was significantly (p = 0.02) lower in Na Citrate by 72 h. In contrast, bacteria opsonized with K2EDTA displayed no growth overtime inside macrophages at any of the time points evaluated. Therefore, CFU/mL were significantly (p < 0.001) lower in K2EDTA than in the other groups at 24, 48, and 72 h post-infection (Fig. 3).

Fig. 3
figure 3

R. equi (log CFU/mL) after RAW264.7 cells were infected with non-opsonized (control) or opsonized (serum or plasma collected with ACD, K2EDTA, Li Heparin, or Na Citrate) bacteria and lysed at 0, 24, 48, and 72 h post-infection. Asterisks (*) indicate significant growths from T0 (p < 0.05). Different letters denote significant (p < 0.05) differences in CFU/mL between groups at a specific timepoint

Full size image

There were no significant differences in the number of infected cells per 300 macrophages or in the number of macrophages infected with 10 or more R. equi at T0. R. equi opsonized with plasma collected with K2EDTA had significantly (p = 0.04) fewer macrophages infected with 10 or more bacteria 24 h post-inoculation.

Discussion

This study shows that the choice of AC significantly influences the results of the selected in vitro assays which are commonly used to study R. equi infection and the efficacy of HIP (Additional file 1: Figs. S1 and S2) [10,11,12,13,14,15,16,17,18,19, 23]. Overall, exposure of R. equi to K2EDTA resulted in inhibition of CFU formation shortly after exposure; this was not observed when other AC were used. This is important as growth inhibition of R. equi is a desirable effect of HIP. Most of the published work evaluating in vitro R. equi growth does not report the type of AC used for plasma collection. Therefore, it is difficult to establish if the effect of the AC was taken into consideration at the time of results interpretation. Failure to do so has led to equivocal efficacy reports in humans [14]. ACD and heparin did not have any significant impact on any of the assays evaluated.

As described for other Gram-negative and positive bacteria [14, 15, 20, 21], direct exposure to K2EDTA in broth resulted in complete inhibition of CFU by 18 h. This is likely the result of the strong Ca2+ and Mg2+ chelating capacity of K2EDTA increasing cell permeability and fragility which may lead to cell lysis [16]. Interestingly, a similar effect was not observed when the other citrate-based AC (Na Citrate and ACD) were used. Citrate-based anticoagulants prevent coagulation by chelating ionized calcium present in the blood to form non-ionized calcium-citrate complexes; however, their chelating effect is weaker than that of K2EDTA, especially for Mg2+ [15, 22]. Heparin, an AC that inhibits coagulation mainly by enhancing the activity of antithrombin III, didn’t show a direct effect on R. equi growth. This was expected as the authors could find no evidence that antithrombin is relevant to bacterial survival.

In addition to the effects seen with K2EDTA, there was a bacteriostatic effect observed the first 12 h post-inoculation with the other plasmas and serum. This is likely the effect of the antimicrobial proteins normally present in these bodily fluids as serum was collected without AC [23].

Intracellular infections were performed using murine macrophages which have been used to study R. equi infection [10, 13, 24]. Opsonization of R. equi with R. equi-specific antibodies increases microorganism uptake by Fcγ receptors of macrophages and enhances their oxidative burst [19, 25, 26]. Moreover, plasma and serum boost R. equi killing by enhancing phagosome-lysosome fusion [27]. Na Citrate significantly decreased intracellular R. equi growth overtime suggesting that sufficient chelation of calcium to weaken cell wall occurs [16], although other mechanism of growth inhibition such as hyperosmolarity of the solution [28, 29] and partial complement inhibition [15] can’t be ruled out. Interestingly, opsonization with plasma collected with K2EDTA resulted in intracellular R. equi growth inhibition but not death in the 72 h period studied. EDTA partially decreased bacterial deposition of C5b9, a multimer that mediates bacterial killing on Neisseria meningitidis [15]. Others have shown that EDTA inhibited CR3-mediated binding on RAW264.7 cells, decreasing phagocytosis of the Gram-negative bacterium Borrelia burgdorferi [30]. The exact mechanism for the lack of R. equi death inside macrophages in our study remains to be determined.

There were no significant differences in the number of infected cells per 300 macrophages or number of macrophages with 10 or more R. equi immediately post-infection suggesting that AC do not affect the initial R. equi uptake by macrophages. The number of macrophages containing 10 or more bacteria after 24 h was significantly lower when EDTA was used. This likely reflects the direct effect of K2EDTA on R. equi growth. Unfortunately, bacterial fluorescence was not reliable past 24 h (data not shown) which limited our ability to evaluate cell replication past this point [31]. Thus, only CFU data are reported for subsequent timepoints.

Conclusion

Anticoagulants significantly influenced the selected R. equi in vitro assays. Specifically, K2EDTA inhibited CFU formation and resulted in intracellular growth inhibition, whereas Na Citrate delayed intracellular growth. Failure to recognize these effects can lead to misinterpretation of the data and inappropriate estimation of product efficacy. The use of ACD and Li Heparin appears to be more appropriate choices for the selected in vitro assays.

Limitations

  • Only one strain has been used for this study (R. equi 103 s-gfp).

Availability of data and materials

Data is available upon request. Please contact Dr Macarena G. Sanz (macarena@wsu.edu).

Abbreviations

AC:

Anticoagulant

ACD:

Acid citrate dextrose

ANOVA:

Analysis of variance

cDMEM:

Complete DMEM

CFU:

Colony forming units

EDTA:

Ethylenediaminetetraacetic acid

HIP:

Rhodococcus equi- Hyperimmune plasma

Li Heparin:

Lithium heparin

Na Citrate:

Sodium citrate

R. equi :

Rhodococcus equi

References

  1. Takai S, Iie M, Watanabe Y, Tsubaki S, Sekizaki T. Virulence-associated 15- to 17-kilodalton antigens in Rhodococcus equi: temperature-dependent expression and location of the antigens. Infect Immun. 1992;60(7):2995–7. https://doi.org/10.1128/IAI.60.7.2995-2997.1992.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Hondalus MK. Pathogenesis and virulence of Rhodococcus equi. Vet Microbiol. 1997;56(3–4):257–68. https://doi.org/10.1016/s0378-1135(97)00094-1.

    Article  CAS  PubMed  Google Scholar 

  3. Reuss SM, Chaffin MK, Cohen ND. Extrapulmonary disorders associated with Rhodococcus equi infection in foals: 150 cases (1987–2007). J Am Vet Med Assoc. 2009;235(7):855–63. https://doi.org/10.2460/javma.235.7.855.

    Article  PubMed  Google Scholar 

  4. Sanz M, Loynachan A, Sun L, Oliveira A, Breheny P, Horohov DW. The effect of bacterial dose and foal age at challenge on Rhodococcus equi infection. Vet Microbiol. 2013;167(3–4):623–31. https://doi.org/10.1016/j.vetmic.2013.09.018.

    Article  CAS  PubMed  Google Scholar 

  5. Becú T, Polledo G, Gaskin JM. Immunoprophylaxis of Rhodococcus equi pneumonia in foals. Vet Microbiol. 1997;56(3–4):193–204.

    Article  Google Scholar 

  6. Sanz MG, Oliveira AF, Page A, Horohov DW. Administration of commercial Rhodococcus equi specific hyperimmune plasma results in variable amounts of IgG against pathogenic bacteria in foals. Vet Rec. 2014;175(19):485. https://doi.org/10.1136/vr.102594.

    Article  CAS  PubMed  Google Scholar 

  7. Kahn SK, Blodgett GP, Canaday NM, Bevevino KE, Rocha JN, Bordin AI, et al. Transfusion with 2 L of hyperimmune plasma is superior to transfusion of 1 L or less for protecting foals against subclinical pneumonia attributed to Rhodococcus equi. J Equine Vet Sci. 2019;79:54–8. https://doi.org/10.1016/j.jevs.2019.05.015.

    Article  PubMed  Google Scholar 

  8. Oliveira AF, Ruas LP, Cardoso SA, Soares SG, Roque-Barreira MC. Vaccination of mice with salmonella expressing VapA: mucosal and systemic Th1 responses provide protection against Rhodococcus equi infection. PLoS ONE. 2010;5(1): e8644. https://doi.org/10.1371/journal.pone.0008644.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Zink MC, Yager JA. Experimental infection of piglets by aerosols of Rhodococcus equi. Can J Vet Res. 1987;51(3):290–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Hondalus MK, Mosser DM. Survival and replication of Rhodococcus equi in macrophages. Infect Immun. 1994;62(10):4167–75.

    Article  CAS  Google Scholar 

  11. Berghaus LJ, Giguère S, Sturgill TL. Effects of age and macrophage lineage on intracellular survival and cytokine induction after infection with Rhodococcus equi. Vet Immunol Immunopathol. 2014;160(1–2):41–50. https://doi.org/10.1016/j.vetimm.2014.03.010.

    Article  CAS  PubMed  Google Scholar 

  12. von Bargen K, Scraba M, Krämer I, Ketterer M, Nehls C, Krokowski S, et al. Virulence-associated protein A from Rhodococcus equi is an intercompartmental pH-neutralising virulence factor. Cell Microbiol. 2019;21(1): e12958. https://doi.org/10.1111/cmi.12958.

    Article  CAS  Google Scholar 

  13. Fernandez-Mora E, Polidori M, Lührmann A, Schaible UE, Haas A. Maturation of Rhodococcus equi-containing vacuoles is arrested after completion of the early endosome stage. Traffic. 2005;6(8):635–53. https://doi.org/10.1111/j.1600-0854.2005.00304.x.

    Article  CAS  PubMed  Google Scholar 

  14. López-Medrano R, Guerra-Laso JM, López-Fidalgo E, Diez-Tascón C, García-García S, Blanco-Conde S, et al. Plasma contributes to the antimicrobial activity of whole blood against Mycobacterium tuberculosis. Innate Immun. 2016;22(7):557–66. https://doi.org/10.1177/1753425916663311.

    Article  CAS  PubMed  Google Scholar 

  15. Strobel L, Johswich KO. Anticoagulants impact on innate immune responses and bacterial survival in whole blood models of Neisseria meningitidis infection. Sci Rep. 2018;8(1):10225. https://doi.org/10.1038/s41598-018-28583-8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Umerska A, Strandh M, Cassisa V, Matougui N, Eveillard M, Saulnier P. Synergistic effect of combinations containing EDTA and the antimicrobial peptide AA230, an arenicin-3 derivative, on gram-negative bacteria. Biomolecules. 2018. https://doi.org/10.3390/biom8040122.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Burton AJ, Giguère S, Berghaus LJ, Hondalus MK, Arnold RD. Efficacy of liposomal gentamicin against Rhodococcus equi in a mouse infection model and colocalization with R. equi in equine alveolar macrophages. Vet Microbiol. 2015;176(3–4):292–300. https://doi.org/10.1016/j.vetmic.2015.01.015.

    Article  CAS  PubMed  Google Scholar 

  18. Lee YJ, Han JY, Lee CG, Heo K, Park SI, Park YS, et al. Korean Red Ginseng saponin fraction modulates radiation effects on lipopolysaccharide-stimulated nitric oxide production in RAW264.7 macrophage cells. J Ginseng Res. 2014;38(3):208–14. https://doi.org/10.1016/j.jgr.2014.02.001.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Dawson DR, Nydam DV, Price CT, Graham JE, Cynamon MH, Divers TJ, et al. Effects of opsonization of Rhodococcus equi on bacterial viability and phagocyte activation. Am J Vet Res. 2011;72(11):1465–75. https://doi.org/10.2460/ajvr.72.11.1465.

    Article  CAS  PubMed  Google Scholar 

  20. Onoda T, Enokizono J, Kaya H, Oshima A, Freestone P, Norris V. Effects of calcium and calcium chelators on growth and morphology of Escherichia coli L-form NC-7. J Bacteriol. 2000;182(5):1419–22. https://doi.org/10.1128/jb.182.5.1419-1422.2000.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Root JL, McIntyre OR, Jacobs NJ, Daghlian CP. Inhibitory effect of disodium EDTA upon the growth of Staphylococcus epidermidis in vitro: relation to infection prophylaxis of Hickman catheters. Antimicrob Agents Chemother. 1988;32(11):1627–31. https://doi.org/10.1128/aac.32.11.1627.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Bouchard J, Madore F. Role of citrate and other methods of anticoagulation in patients with severe liver failure requiring continuous renal replacement therapy. NDT Plus. 2009;2(1):11–9. https://doi.org/10.1093/ndtplus/sfn184.

    Article  CAS  PubMed  Google Scholar 

  23. Lagergard T, Frisk A, Purven M, Nilsson LA. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi. Microb Pathog. 1995;18(1):37–51.

    Article  CAS  Google Scholar 

  24. Darrah PA, Monaco MC, Jain S, Hondalus MK, Golenbock DT, Mosser DM. Innate immune responses to Rhodococcus equi. J Immunol. 2004;173(3):1914–24. https://doi.org/10.4049/jimmunol.173.3.1914.

    Article  CAS  PubMed  Google Scholar 

  25. Hietala SK, Ardans AA. Interaction of Rhodococcus equi with phagocytic cells from R. equi-exposed and non-exposed foals. Vet Microbiol. 1987;14(3):307–20. https://doi.org/10.1016/0378-1135(87)90118-0.

    Article  CAS  PubMed  Google Scholar 

  26. Rosales C. Fc receptors: cell activators of antibody functions. Adv Biosci Biotechnol. 2013;4:21–33.

    Article  Google Scholar 

  27. Cauchard J, Sevin C, Ballet JJ, Taouji S. Foal IgG and opsonizing anti-Rhodococcus equi antibodies after immunization of pregnant mares with a protective VapA candidate vaccine. Vet Microbiol. 2004;104(1–2):73–81. https://doi.org/10.1016/j.vetmic.2004.09.006.

    Article  CAS  PubMed  Google Scholar 

  28. Ash SR, Mankus RA, Sutton JM, Criswell RE, Crull CC, Velasquez KA, et al. Concentrated sodium citrate (23%) for catheter lock. Hemodial Int. 2000;4(1):22–31. https://doi.org/10.1111/hdi.2000.4.1.22.

    Article  PubMed  Google Scholar 

  29. Yon CK, Low CL. Sodium citrate 4% versus heparin as a lock solution in hemodialysis patients with central venous catheters. Am J Health Syst Pharm. 2013;70(2):131–6. https://doi.org/10.2146/ajhp120300.

    Article  CAS  PubMed  Google Scholar 

  30. Hawley KL, Olson CM, Iglesias-Pedraz JM, Navasa N, Cervantes JL, Caimano MJ, et al. CD14 cooperates with complement receptor 3 to mediate MyD88-independent phagocytosis of Borrelia burgdorferi. Proc Natl Acad Sci U S A. 2012;109(4):1228–32. https://doi.org/10.1073/pnas.1112078109.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Ward WW, Bokman SH. Reversible denaturation of Aequorea green-fluorescent protein: physical separation and characterization of the renatured protein. Biochemistry. 1982;21(19):4535–40. https://doi.org/10.1021/bi00262a003.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This study was funded by intramural Grant from the Department of Veterinary Clinical Sciences at Washington State University.

Author information

Authors and Affiliations

  1. Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Washington State University, Pullman, WA, USA

    Alejandra A. Rivolta, Dana C. Pittman, Amanda J. Kappes & Macarena G. Sanz

  2. Department of Mathematics, Washington State University, Pullman, WA, USA

    Robert K. Stancil & Clark Kogan

Authors
  1. Alejandra A. Rivolta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dana C. Pittman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Amanda J. Kappes
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Robert K. Stancil
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Clark Kogan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Macarena G. Sanz
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Study was designed by AAR and MGS. Data collection was conducted by AAR, DCP, and AJK. Data analysis and statistics were done by AAR, RKS, CK, and MGS. Preparation of manuscript was done by AAR and MGS. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Macarena G. Sanz.

Ethics declarations

Ethics approval for consent to participate

The horses used for this study belong to Washington State University research herd. Procedures for blood collection were reviewed and approved by the WSU Institutional Animal Care and Use Committee (ASAF # 6522).

Consent for publication

Not applicable.

Competing interests

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Figure S1.

R. equi (log CFU/mL) after either 0.5 mL of R. equi-specific HIP (HIP-Re) or hyperimmune plasma not specific for R. equi (HIP-NoRe) were mixed with 1.5 mL of BHI containing 1-3 × 104 CFU/mL of R. equi for 36 h at 37 °C. All plasmas were collected using sodium citrate. CFU/mL were counted immediately after mixing (T0) and 12, 18 and 24 h thereafter. BHI was added as control. Statistical significance between groups is noted in the graph. Figure S2. R. equi (log CFU/mL) after 1x105 RAW264.7 cells were infected with non-opsonized (control) or opsonized with R. equi-specific HIP (HIP-Re) or serum R. equi at a MOI 20 for 1 h. Infected cells were lysed at 0, 24, 48, and 72 h post-infection, were plated in BHI agar plates and bacterial colonies were counted 48 h later. Statistical significance between groups is noted in the graph.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rivolta, A.A., Pittman, D.C., Kappes, A.J. et al. The type of anticoagulant used for plasma collection affects in vitro Rhodococcus equi assays. BMC Res Notes 15, 50 (2022). https://doi.org/10.1186/s13104-022-05933-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13104-022-05933-4

Keywords

BMC Research Notes

ISSN: 1756-0500

Contact us